| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.036 | 0.5 |